Profile data is unavailable for this security.
About the company
Theranexus SA is a France-based company engaged in the healthcare industry. The Company is a biopharmaceutical entity that develops drug candidates to be used in the treatment of central nervous system (CNS) disorders, including epilepsy, narcolepsy, Parkinson's disease, Alzheimer's disease, neuropathic pain and psychiatric disorders. Its patented technology is aimed at increasing the efficacy of CNS drugs, which are approved and available on the market. The Company's technology is protected, scalable and versatile, and used to generate high value-added proprietary drug candidates for different conditions, while reducing time-to-market and market entry costs and risks in comparison with standard drug development processes. Theranexus SA operates in the domestic market.
- Revenue in EUR (TTM)0.00
- Net income in EUR-3.08m
- Incorporated2013
- Employees12.00
- LocationTheranexus SA60Avenue Rockefeller - Pepiniere LaennecLYON 69008FranceFRA
- Phone+33 188897031
- Websitehttps://www.theranexus.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biophytis SA | 0.00 | -15.07m | 1.23m | 22.00 | -- | -- | -- | -- | -6.54 | -6.54 | 0.00 | -1.22 | 0.00 | -- | -- | 0.00 | -129.28 | -97.52 | -- | -487.25 | -- | -- | -- | -- | -- | -5.75 | 5.28 | -- | -- | -- | 29.69 | -- | 14.25 | -- |
| Medesis Pharma SA | 0.00 | -3.96m | 2.03m | 10.00 | -- | -- | -- | -- | -0.7916 | -0.7916 | 0.00 | -0.9071 | 0.00 | 0.3139 | -- | -- | -206.12 | -126.10 | -- | -300.50 | -- | 70.78 | -- | -2,552.19 | 0.467 | -26.37 | -- | -- | -- | -- | -44.04 | -- | -- | -- |
| GeNeuro SA | 0.00 | -14.76m | 2.33m | 19.00 | -- | -- | -- | -- | -0.594 | -0.594 | 0.00 | -0.5548 | 0.00 | -- | -- | 0.00 | -165.51 | -96.43 | -356.72 | -185.61 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -20.96 | -- | -20.13 | -- |
| IntegraGen SA | 12.54m | -171.40k | 3.43m | 55.00 | -- | 1.68 | 127.97 | 0.2737 | -0.025 | -0.025 | 1.90 | 0.3041 | 1.47 | 12.06 | 4.06 | 227,953.30 | -2.01 | -1.93 | -4.78 | -4.41 | 66.41 | 65.11 | -1.37 | -1.51 | 1.57 | -- | 0.3587 | -- | -4.78 | 12.61 | -4,783.19 | -- | -- | -- |
| Theranexus SA | 0.00 | -3.08m | 3.94m | 12.00 | -- | -- | -- | -- | -0.3971 | -0.3971 | 0.00 | -0.0004 | 0.00 | -- | -- | 0.00 | -50.35 | -42.66 | -64.95 | -47.97 | -- | -- | -- | -- | -- | -420.89 | 1.00 | -- | -- | -- | -3.97 | -- | -33.23 | -- |
| Quantum Genomics SA | 0.00 | -9.40m | 5.03m | 3.00 | -- | -- | -- | -- | -0.1519 | -0.1519 | 0.00 | -0.0255 | 0.00 | -- | -- | 0.00 | -282.86 | -60.77 | -422.81 | -102.24 | -- | -3,548.91 | -- | -3,374.13 | -- | -131.78 | 3.97 | -- | -98.34 | -- | 87.28 | -- | -- | -- |
| Acticor Biotech SA | 0.00 | -15.86m | 5.50m | 28.00 | -- | -- | -- | -- | -1.15 | -1.15 | 0.00 | -0.4011 | 0.00 | -- | -- | 0.00 | -129.36 | -- | -695.94 | -- | -- | -- | -- | -- | -- | -- | 3.71 | -- | -- | -- | -17.40 | -- | -- | -- |
| Poxel SA | 1.98m | -35.09m | 13.88m | 22.00 | -- | -- | -- | 7.01 | -1.08 | -1.08 | 0.0591 | -1.27 | 0.1002 | -- | 5.09 | 90,045.45 | -177.50 | -52.39 | -- | -92.20 | 0.0505 | -- | -1,771.33 | -299.15 | -- | -1.39 | -- | -- | 193.92 | -49.84 | -11.76 | -- | -- | -- |
| Plant Advanced Technologies PAT SA | 2.53m | 1.09m | 14.37m | 27.00 | 12.94 | -- | 9.11 | 5.67 | 0.9967 | 0.9967 | 2.32 | -- | -- | -- | -- | 93,777.41 | -- | -3.53 | -- | -4.39 | 110.03 | 134.21 | 43.01 | -33.16 | -- | 12.90 | -- | -- | 8.56 | 8.05 | 119.67 | -38.00 | -- | -- |
| Predilife SA | 317.79k | -4.22m | 14.50m | 19.00 | -- | -- | -- | 45.63 | -1.14 | -1.14 | 0.0858 | -1.06 | 0.0695 | -- | 2.05 | 17,030.55 | -92.43 | -89.36 | -129.39 | -123.81 | 97.25 | 83.94 | -1,329.21 | -1,901.22 | -- | -6.23 | 2.20 | -- | 10.11 | 79.85 | -15.58 | -- | -18.51 | -- |
| Phaxiam Therapeutics SA | 2.14m | -21.92m | 17.62m | 54.00 | -- | 0.692 | -- | 8.23 | -3.46 | -3.46 | 0.3956 | 2.54 | 0.0409 | -- | 8.56 | 41,980.39 | -41.90 | -50.69 | -61.11 | -66.25 | -- | -- | -1,023.96 | -1,009.09 | -- | -70.91 | 0.4556 | -- | -80.05 | -21.50 | -10,201.75 | -- | -56.68 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Gestys SAas of 30 Aug 2024 | 17.50k | 0.23% |
